Tue, August 10, 2021
Mon, August 9, 2021
Fri, August 6, 2021
Thu, August 5, 2021
Wed, August 4, 2021

Mani Foroohar Maintained (BBIO) at Buy with Decreased Target to $66 on, Aug 6th, 2021

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-66-on-aug-6th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Mani Foroohar of SVB Leerink, Maintained "BridgeBio Pharma, Inc." (BBIO) at Buy with Decreased Target from $71 to $66 on, Aug 6th, 2021.

Mani has made no other calls on BBIO in the last 4 months.



There are 2 other peers that have a rating on BBIO. Out of the 2 peers that are also analyzing BBIO, 0 agree with Mani's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Mani


  • Eliana Merle of "UBS" Initiated at Strong Buy and Held Target at $80 on, Friday, May 21st, 2021
  • Paul Choi of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $80 on, Friday, May 7th, 2021